# Abbvie Biotechnology Ltd. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/abbvie-biotechnology-ltd/b438b15a-033c-469a-8973-66b6506bba41

> Inspection records and compliance data for Abbvie Biotechnology Ltd. in Barceloneta, Puerto Rico. Access full analysis and detailed observations.

---

## Details

- Name: Abbvie Biotechnology Ltd.
- FEI Number: 3004620772
- City: Barceloneta
- State: Puerto Rico
- Country Name: United States
- Address Line 1: Road No 2 Km 59.2
- Zip Code: 00617

## Related Documents

- [483 - Abbvie Biotechnology Ltd. - Unknown Date](https://www.globalkeysolutions.net/records/483/abbvie-biotechnology-ltd/b841e8d1-f95e-4ef1-bf9f-48c8f728cd44) — source: FDA, date: Invalid Date
- [483 - Abbvie Biotechnology Ltd. - 2023-10-30](https://www.globalkeysolutions.net/records/483/abbvie-biotechnology-ltd/9720fdfe-bc68-465d-82ae-4663e933a7ae) — source: FDA, date: October 30, 2023
- [483 - Abbvie Biotechnology Ltd. - 2023-10-30](https://www.globalkeysolutions.net/records/483/abbvie-biotechnology-ltd/fc6e7103-fba8-48a2-aaec-eae25e1f9e30) — source: FDA, date: October 30, 2023
- [FDA Inspection 1222107 - Abbvie Biotechnology Ltd. - 2023-10-30](https://www.globalkeysolutions.net/records/fda_inspections/abbvie-biotechnology-ltd/fbc58704-0c5e-4f2c-8caa-a8e38cd2ba1a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 30, 2023
- [483 - Abbvie Biotechnology Ltd. - 2019-03-25](https://www.globalkeysolutions.net/records/483/abbvie-biotechnology-ltd/21216898-f0d2-4e1d-a352-c04132283cdb) — source: FDA, date: March 25, 2019
- [FDA Inspection 1084057 - Abbvie Biotechnology Ltd. - 2019-03-25](https://www.globalkeysolutions.net/records/fda_inspections/abbvie-biotechnology-ltd/8a1c2a7f-d230-419e-8259-9a4045db92d1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 25, 2019
- [FDA Inspection 1055102 - Abbvie Biotechnology Ltd. - 2018-06-01](https://www.globalkeysolutions.net/records/fda_inspections/abbvie-biotechnology-ltd/6ebd3fac-5fb5-4657-a309-9546c0d43e1b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 1, 2018
- [FDA Inspection 1012249 - Abbvie Biotechnology Ltd. - 2017-04-28](https://www.globalkeysolutions.net/records/fda_inspections/abbvie-biotechnology-ltd/086cba85-e6e5-48ec-a35e-02b4f9600118) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 28, 2017
- [FDA Inspection 969277 - Abbvie Biotechnology Ltd. - 2016-03-24](https://www.globalkeysolutions.net/records/fda_inspections/abbvie-biotechnology-ltd/5800f07b-684a-4070-bd7c-4ec2bbc0b14f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 24, 2016
- [FDA Inspection 887947 - Abbvie Biotechnology Ltd. - 2014-07-16](https://www.globalkeysolutions.net/records/fda_inspections/abbvie-biotechnology-ltd/0aeefd43-5395-44aa-82c5-ebf1fb1a8c67) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 16, 2014
- [FDA Inspection 791758 - Abbvie Biotechnology Ltd. - 2012-07-12](https://www.globalkeysolutions.net/records/fda_inspections/abbvie-biotechnology-ltd/f0aad22a-29ca-4979-9fe3-413e39afee79) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 12, 2012
- [FDA Inspection 720207 - Abbvie Biotechnology Ltd. - 2011-04-29](https://www.globalkeysolutions.net/records/fda_inspections/abbvie-biotechnology-ltd/cdd40822-5b41-43d4-b781-326202615310) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 29, 2011
- [FDA Inspection 575712 - Abbvie Biotechnology Ltd. - 2009-03-04](https://www.globalkeysolutions.net/records/fda_inspections/abbvie-biotechnology-ltd/8fcf6dbb-ba7a-4b7f-92ba-567c15b038ba) — classification: No Action Indicated (NAI), source: FDA, date: March 4, 2009

## Related Companies

- [Immunex Rhode Island Corporation](https://www.globalkeysolutions.net/companies/immunex-rhode-island-corporation/c70ebfcc-0c4d-4294-845a-24f1af8f30e9)
- [Sanofi Winthrop Industrie](https://www.globalkeysolutions.net/companies/sanofi-winthrop-industrie/f7668868-7954-441c-b8bf-ab135e8645c2)
- [Regeneron Pharmaceuticals Inc](https://www.globalkeysolutions.net/companies/regeneron-pharmaceuticals-inc/cd765cfa-95e6-4023-ade2-0ffa382fe2c7)
- [Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.](https://www.globalkeysolutions.net/companies/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/d07820ec-a994-41cb-b667-509183a6cc4a)
- [Genzyme Corporation](https://www.globalkeysolutions.net/companies/genzyme-corporation/b597b205-d758-426b-bc64-09970b3a1b83)
- [Wyeth Pharmaceutical Division of Wyeth Holdings LLC](https://www.globalkeysolutions.net/companies/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/85fd73c7-1b97-4ac5-bc70-53dfb31c37e5)
- [BSP Pharmaceuticals SpA](https://www.globalkeysolutions.net/companies/bsp-pharmaceuticals-spa/cbf52ec3-50e2-4cf1-9f81-f0f7a74473fc)
- [Hovione LLC](https://www.globalkeysolutions.net/companies/hovione-llc/06b4417a-5377-4e73-8076-71d3066fa8f0)
- [Amgen Singapore Manufacturing Pte Ltd](https://www.globalkeysolutions.net/companies/amgen-singapore-manufacturing-pte-ltd/ff869a15-a7c2-441a-8165-7fd77928331e)
- [Alexion Pharma International Operations Unlimited Co.](https://www.globalkeysolutions.net/companies/alexion-pharma-international-operations-unlimited-co/7c523c79-b4b1-4a47-8393-141753fd60e8)

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/noreen-muniz/0bb20d12-62ad-42aa-8b0a-c44b339d413f)
- [Lilia M Lugo](https://www.globalkeysolutions.net/people/lilia-m-lugo/bd409997-f589-4d2d-b7ba-4b52f222e43e)
- [Quality System Specialist](https://www.globalkeysolutions.net/people/jose-e-melendez/75bd6083-14a4-4bd2-a0e5-9946d4dd37e1)